Prestige Consumer Healthcare Inc. (NYSE:PBH) will be hosting a conference call at 8:30 AM eastern time on 5th November 2020, to discuss its 2Q21 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.prestigebrands.com
Earnings Expectation
Prestige Consumer Healthcare Inc. is set to announce second quarter earning results on Thursday 5th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, PBH to report 2Q21 income of $ 0.72 per share from revenue of $ 227.42 million. For the full year, analysts anticipate top line of $ 940.20 million, while looking forward to income of $ 3.17 per share bottom line.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers BC/Goodys analgesic powders, Boudreauxs Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief.
